Ajanta Pharma on Thursday reported 28.90 per cent rise in consolidated net profit to ₹147.76 crore for the quarter ended June 30 mainly on account of robust exports.
The company had posted a net profit of ₹114.63 crore for the year-ago same period, the drug firm said in a filing to BSE.
Revenue from operations surged to ₹668.20 crore during the quarter under review from ₹611.94 crore in the same period of 2019-20, it added.
Total export sales in the quarter were at ₹483 crore as against ₹404 crore in the year-ago period, registering a growth of 19 per cent, the company said.
Shares of Ajanta Pharma settled at ₹1,512.15 apiece, up 1.52 per cent from the previous close on BSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.